INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 435m ago
House PTR34m ago
SEC 13F34m ago
Robinhood Chain34m ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.70B / 21S · 11 late91 trades$26.34M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 33S33 trades$5.33M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

68,655 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
2
CT
Chuang Patrick T.Senior VP, Memory Design
GSITGSI TECHNOLOGY INC
Grant or award
A—
40.0K sh
Aug 13, 2026Aug 14, 2026
Page 533 of 1717
← PrevNext →
traded Aug 13, 2026
+1d
SEC Form 4

Evidence

1
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Open-market sale · 10b5-1 plan
SELL$1,505
43 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

1
SC
Shackley Brian CharlesSVP, Chief Accounting Officer
AVAVAeroVironment Inc
Open-market sale · 10b5-1 plan
SELL$41K
205 sh
Aug 14, 2026Aug 14, 2026
traded Aug 14, 2026
+0dSEC Form 4

Evidence

1
HS
Hooker David StevensDirector
NPBNORTHPOINTE BANCSHARES INC
Open-market sale · 10b5-1 plan
SELL$5,943
339 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

1
HS
Hooker David StevensDirector
NPBNORTHPOINTE BANCSHARES INC
Open-market sale · 10b5-1 plan
SELL$421
24 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise · 10b5-1 plan
M$633
43 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
16.1K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

0
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M—
555.6K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

0
LD
Larson Keith DGeneral Counsel and Secretary
VGVenture Global, Inc.
Option exercise · 10b5-1 plan
M$439K
555.6K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

0
RM
Rezvan MitraChief Accounting Officer
SAILSailPoint, Inc.
Open-market sale · 10b5-1 plan
SELL$24K
1,214 sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

0
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M$230K
3,348 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

0
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M—
7,171 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

0
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M—
2,074 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

0
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M—
3,348 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

0
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M$160K
2,869 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

0
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$168K
16.1K sh
Aug 13, 2026Aug 14, 2026
traded Aug 13, 2026
+1dSEC Form 4

Evidence

0
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M—
16.2K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

0
MP
McNamara PeterChief Scientific Officer
TECXTectonic Therapeutic, Inc.
Option exercise · 10b5-1 plan
M—
43 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

0
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M$145K
2,074 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

0
DB
Dageville BenoitDirector
SNOWSnowflake Inc.
Gift · 10b5-1 plan
G—
16.7K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

0
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Option exercise · 10b5-1 plan
M—
2,869 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC Form 4

Evidence

60
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market purchase
BUY$1.78M
85.0K sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

59
CS
Clark Stephen SChief People Officer
AMRZAmrize Ltd
Open-market purchase
BUY$249K
5,260 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

59
OB
Oran BarisChief Financial Officer
AMRZAmrize Ltd
Open-market purchase
BUY$142K
3,000 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

55
OB
Oran BarisChief Financial Officer
AMRZAmrize Ltd
Open-market purchase
BUY$141K
3,000 sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

52
WC
Walsh ColinDirector
ATTOAttovia Therapeutics, Inc.
Open-market sale
SELL$1.61M
76.4K sh
Aug 5, 2026Aug 13, 2026
traded Aug 5, 2026
+8dSEC Form 4

Evidence

51
BB
Binkowski BrentCHIEF OPERATING OFFICER
CVRXCVRx, Inc.
Open-market purchase
BUY$76K
26.2K sh
Aug 13, 2026Aug 13, 2026
traded Aug 13, 2026
+0dSEC Form 4

Evidence

50
HG
Harbison Richard GEVP, Refining
PSXPhillips 66
Open-market sale
SELL$11.66M
52.1K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

49
LG
Littleton GayleCLO, CCO, CAO & Corp Sec
HOGHARLEY-DAVIDSON, INC.
Open-market purchase
BUY$198K
7,500 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

47
GM
Gross MarioChief Supply Chain Officer
AMRZAmrize Ltd
Open-market purchase
BUY$149K
3,200 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

47
BR
Brouwer RoaldChief Technology Officer
AMRZAmrize Ltd
Open-market purchase
BUY$70K
1,500 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

47
HJ
Hill JaimePresident, Building Materials
AMRZAmrize Ltd
Open-market purchase
BUY$71K
1,500 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

46
AL
Aviram LiorDirector
CAMTCAMTEK LTD
Open-market sale
SELL$274K
1,689 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

46
HA
Hoxworth Seth AlanChief Actuary
CIACITIZENS, INC.
Open-market purchase
BUY$21K
5,376 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

46
FF
Fleming William Fred JrSVP, Corporate Controller
PCORPROCORE TECHNOLOGIES, INC.
Open-market sale
SELL$590K
10.0K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

46
EM
Eisenberg MosheChief Financial Officer
CAMTCAMTEK LTD
Open-market sale
SELL$602K
3,759 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

46
AL
Aviram LiorDirector
CAMTCAMTEK LTD
Open-market sale
SELL$272K
1,658 sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

45
VD
Viglianco DiegoEVP & CIO
EVTCEVERTEC, Inc.
Open-market sale
SELL$836K
27.6K sh
Aug 12, 2026Aug 13, 2026
traded Aug 12, 2026
+1dSEC Form 4

Evidence

44
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$5.00M
56.2K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence

44
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$3.02M
33.6K sh
Aug 11, 2026Aug 13, 2026
traded Aug 11, 2026
+2dSEC Form 4

Evidence